Effect of L/N-type Calcium Channel Blocker (Cilnidipine) on Oxidative Stress in Nitric Oxide-deficient Hypertensive Rats

被引:0
|
作者
Shaikh, Gouher B. [1 ]
Hippargi, Surekha [2 ]
Majid, Dewan S. A. [3 ]
Biradar, M. S. [4 ]
Das, Kusal K. [1 ]
机构
[1] Tulane Univ, Lab Vasc Physiol & Med, Dept Physiol, New Orleans, LA 70118 USA
[2] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA
[3] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[4] BLDE Deemed Be Univ, Shri BM Patil Med Coll Hosp & Res Ctr, Dept Med, Vijayapura 586103, Karnataka, India
关键词
Nitric Oxide Deficient Hypertension; Oxidative Stress; Mean Arterial Pressure; Malondialdehyde;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The sympathetic nervous system plays a major role on the renal function through the vasoactive system and the renin-angiotensin aldosterone system. Even though interest in the renal protective effects of sympathetic blocker has been increased, there are not much data to clarify this efficiency in nitric oxide deficient hypertensive rats. Aim and Objectives: To find out the effect of cilnidipine, L/N-type calcium channel blocker on oxidative stress of kidney in Nitric Oxide Synthase (NOS) inhibited experimental hypertensive rats. Material and Methods: Male Albino Wistar rats (n-24) were randomly allocated into four groups: Group 1 control received vehicle; Group 2 received Cilnidipine; Group 3 received N-G-nitro-L-Arginine Methyl Ester NAME) hydrochloride; Group 4 received L-NAME and Cilnidipine; All drugs are given orally for 4 weeks. Blood pressure was measured before and after intervention and twice during intervention for all the rats. On 29th day, blood was collected and animals were sacrificed and kidneys were collected. Serum and kidney tissue Malondialdehyde (MDA) levels are estimated. Results: The results demonstrate that there is a significant increase in Mean Arterial Pressure (MAP) in L-NAME treated rats compared to control group. Treatment with cilnidipine significantly decreases the MAP in Group 4 rats. We also demonstrated the significant elevated serum and kidney tissue MDA levels in L-NAME treated rats. Treatment with Cilnidipine reduced serum and kidney tissue MDA levels in Group 4 rats as compared to Group 3 rats. Conclusion: The results demonstrate that cilnidipine has suppressive effects against progressive renal injury as evidenced by decrease oxidative stress indicator MDA levels in NO deficient hypertensive rats. This effect is explained by the L/N type calcium channel inhibition of Cilnidipine, the L-type calcium channel blocking action lowers blood pressure and N-type calcium channel blocking action leads to suppression of the sympathetic nerve activity and renin-angiotensin aldosterone system.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [31] Antianginal effects of L-type and N-type calcium channel blocker cilnidipine assessed using the vasopressin-induced experimental angina model of rats
    Saitoh, M
    Sugiyama, A
    Nakamura, Y
    Hashimoto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 152P - 152P
  • [32] Antimigraine effects of an L/N-type Ca2+ channel blocker cilnidipine in the rat
    Masuda, R.
    Hamada, J.
    Koizumi, K.
    Yonekura, J.
    Kitamura, E.
    Sakai, F.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S269 - S270
  • [33] Renoprotective effects of cilnidipine, N type calcium channel blocker, in patients with hypertensive subjects complicated with proteinuria
    Hatta, Tsuguru
    Kusaba, Tetsuro
    Kimura, Taiko
    Sonomura, Kazuhiro
    Tanda, Shuji
    Kameyama, Hisako
    Mori, Yasukiyo
    Takeda, Kazuo
    Sasaki, Susumu
    JOURNAL OF HYPERTENSION, 2006, 24 : 291 - 291
  • [34] Renal protective effects of L/N-type calcium channel antagonist cilnidipine in salt sensitive Dahl rats
    Konda, T
    Enomoto, A
    Okano, A
    Yoshimoto, R
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 273P - 273P
  • [35] Cilnidipine, an L/N-type calcium channel blocker prevents acquisition and expression of ethanol-induced locomotor sensitization in mice
    Bhutada, Pravinkumar
    Mundhada, Yogita
    Patil, Jayshree
    Rahigude, Anand
    Zambare, Krushna
    Deshmukh, Prashant
    Tanwar, Dhanshree
    Jain, Kishor
    NEUROSCIENCE LETTERS, 2012, 514 (01) : 91 - 95
  • [36] Antiproteinuric effect of an N-type calcium antagonist, cilnidipine
    Ueno, M
    Tsuchihashi, T
    Tominaga, M
    Kajioka, T
    Goto, K
    JOURNAL OF HYPERTENSION, 2002, 20 : S240 - S240
  • [37] Renoprotective effects of the N- and L-type calcium channel blocker cilnidipine in combination with an angiotensin II type 1 receptor blocker in Dahl salt-sensitive hypertensive rats
    Aritomi, Shizuka
    Konda, Tomoyuki
    Wagatsuma, Hirotaka
    Koganei, Hajime
    Mitsui, Akira
    JOURNAL OF HYPERTENSION, 2006, 24 : 292 - 292
  • [38] N/L TYPE CALCIUM CHANNEL BLOCKER, CILNIDIPINE, LEADS TO LESS ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM COMPARED WITH L TYPE CALCIUM CHANNEL BLOCKER, AMLODIPINE BESILATE
    Konoshita, T.
    Kimura, T.
    Makino, Y.
    Fujii, M.
    Wakahara, S.
    Arakawa, K.
    Inoki, I.
    Miyamori, I.
    JOURNAL OF HYPERTENSION, 2009, 27 : S6 - S6
  • [39] N/L TYPE CALCIUM CHANNEL BLOCKER, CILNIDIPINE, LEADS TO LESS ELEVATION OF PLASMA ALDOSTERONE COMPARED TO L TYPE CALCIUM CHANNEL BLOCKER, AMLODIPINE BESILATE ON THE TOP OF VALSARTAN
    Konoshita, T.
    Nakaya, T.
    Sakai, I.
    Yamamoto, K.
    Yamada, M.
    Ichikawa, M.
    Sato, S.
    Imagawa, M.
    Makino, Y.
    Fujii, M.
    Zenimaru, Y.
    Suzuki, J.
    Ishizuka, T.
    JOURNAL OF HYPERTENSION, 2015, 33 : E451 - E452
  • [40] Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs
    Takahara, Akira
    Iwasaki, Hiroshi
    Nakamura, Yuji
    Sugiyama, Atsushi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 565 (1-3) : 166 - 170